|
Patent landscape, scope, and claims: |
United States Patent 9,149,579 (Method for Actuating a Medical Injector With Status Window and Moving Visual Indicator): claim scope, infringement touchpoints, and US patent landscape
Executive summary
- US 9,149,579 claims a method for using a medical injector (including auto-injectors) that has (i) an outer housing with a status window, (ii) an inner housing holding a piston member and an elastomeric member, (iii) an energy storage member actuated by an actuator to move the piston, which in turn moves the elastomeric member, and (iv) a visual indicator that moves with the piston from a first to second indicator position, with pre-activation information viewable via the status window and post-activation confirmation viewable via the status window when the indicator is in the second position.
- The claim set is broad enough to cover two mainstream mechanical design families: (a) needle-based medicament auto-injectors with a visible “armed/ready” window and a “delivered/activated” window confirmation, and (b) injector designs using an energy source such as a gas container (compressed gas) paired with a moving elastomeric member and piston.
- Practically, the claim scope centers on the coupling of (1) a moving indicator’s position with (2) post-actuation status viewable through the same status window and on method steps tying those features to the sequence of placing, pre-checking, actuation, and post-activation viewing.
1. What is the claim scope of US 9,149,579, and what elements are required for infringement?
Core infringement requirement: performing the claimed method steps using a medical injector system that has the claimed structural relationships (outer housing, status window, inner housing, piston, elastomeric member, indicator, energy storage, actuator) arranged so that the indicator moves with the piston and provides pre-activation and post-activation indications through the status window.
Required claim elements (independent claim 1)
Claim 1 requires, in order:
- Placing an outer housing associated with a medical injector into contact with a body.
- The outer housing:
- Defines a status window.
- Encloses an inner housing, a piston member, an energy storage member, and an indicator.
- Piston-to-elastomer coupling:
- The piston member is at least partially disposed within the inner housing and in contact with an elastomeric member disposed therein.
- Two elastomer positions:
- Elastomeric member is in a first position associated with pre-activation status prior to placing the outer housing into contact with the body.
- First indication associated with the pre-activation status is viewable via the status window.
- Actuation step:
- Actuating an actuator releases energy stored in the energy storage member to produce force to move the piston member.
- Elastomer movement and indicator movement:
- Elastomer moves from first position to second position in response to piston movement.
- The indicator is configured to move with the piston member from a first indicator position to a second indicator position.
- Second indication:
- Second indicator position is associated with post-activation status.
- Indicator provides a second indication viewable via the status window when indicator is in the second position.
What the dependent claims add (claim strategy and fallback positions)
- Claim 2: narrows inner housing to a medicament container; piston movement expels medicament.
- Claim 3: makes the “first indication” include visible features such as the piston member, elastomer, or contents; it also adds an express method step: view before placing.
- Claim 4: specifies the indicator exposes a colored portion for post-activation indication.
- Claim 5: adds a configuration where:
- medicament is viewable through the status window to indicate pre-activation,
- indicator in second position is spaced apart from elastomer.
- Claim 6: energy storage can be compressed gas and includes gas chamber release to drive piston; adds directional behavior: indicator moves with piston in opposite direction (indicator proximal; piston distal).
- Claim 7: introduces a contact member movably coupled to distal housing end contacting the body target surface; indicator moves when contact member is stationary relative to housing.
- Claims 8-21: provide parallel method formulations that rearrange which parts are emphasized:
- Claim 8 is another independent-style method reciting viewing the contents via status window prior to actuation, then moving an actuator relative to outer housing to actuate energy release and producing visual indication when indicator is in the second position.
- Claims 9-11 focus on visibility logic (obstructed first position, visible second; colored portion; proximal-distal movement correlation).
- Claims 12-13 focus on medicament container plus optional discolored medicament check pre-use.
- Claims 14-16 include functional guard removal and needle/sheath behavior after delivery.
- Claims 17-21 pivot to a method that starts with viewing the contents through status window while indicator is in first position, then places a contact member on target surface and moves actuator to cause piston/container transition and indicator transition to deliver and visually confirm.
Practical scope notes for enforcement
- The claims are drafted as method claims, so infringement hinges on use of a system in a way that satisfies the method steps (placing, viewing, actuation, and post-activation viewing with indicator position).
- The most legally “sticky” elements are:
- Indicator configured to move with piston member (positional coupling),
- Indicator provides post-activation indication viewable via the status window only when indicator is in second position, and
- Pre-activation status indication viewable via status window before placing.
2. How do claim 1 and claim 8 differ, and which is broader for design-around?
Claim 1 is more explicit that:
- Elastomeric member is in a first position prior to placing into contact with the body, and
- The indicator movement and second indication are tied to actuating an actuator during the placement context.
Claim 8 is more explicit that:
- The method includes viewing when the elastomeric member is in first position and the indicator is in first indicator position, and
- The indicator moves to second indicator position after the actuator is moved, and
- The indicator produces visual indication when the elastomeric member is in second position and indicator is in second position.
Design-around implication
- A design that decouples indicator movement from piston movement, or that places the second post-activation confirmation outside the status window (or not viewable via the same status window) is the most direct attempt to escape both claims.
- A design that preserves indicator movement but changes the “when/where viewed” step may still fall within the method framework because both independent claim formats include “viewing” elements tied to indicator and status window positions.
3. What does “status window” and “visual indication viewable through the status window” cover?
The claim language supports several in-window architectures:
- Direct visualization of internal contents (e.g., medicament discolored check) through the status window.
- Supported by claim 3 (“contents… viewable via the status window”) and claim 5/13/16/17/19/20.
- Window-confirmed post-actuation indicator:
- Supported by claim 1/8 and dependent claim 4 (colored portion) plus claims 9-11 (obstruction in first position; visible in second position).
- Indicator positioned to be spaced apart from elastomer in some embodiments:
- Supported by claim 5 (indicator spaced apart from elastomeric member).
Most defensible read for infringement
- The status window must enable a user to view the pre-activation condition (first indication) and later view the post-activation condition (second indication) when the indicator reaches the second position.
4. What injector mechanics and energy storage designs are captured by US 9,149,579?
Energy storage member embodiments in the claims
- Compressed gas container with gas chamber release sufficient to move piston (claim 6).
- The independent claims are not limited to gas. They require an energy storage member and an actuator releasing stored energy to move the piston.
Mechanical motion correlations
- Claim 1:
- Elastomer moves in response to piston movement.
- Indicator moves with piston member.
- Claim 6:
- Adds directional behavior: piston distal movement; indicator proximal direction.
- Claim 7:
- Indicator movement occurs when a contact member is stationary relative to outer housing.
- Claim 15/16/19:
- Auto-injector with needle movement outside the housing; post-use sheath coverage.
Interpretation for landscape mapping
- Competitors using gas-actuated piston systems with an elastomer-driven seal and a movable window indicator are the closest technical overlap.
5. How do claims 15, 16, and 19 expand coverage for needle auto-injectors and sheathed needles?
These dependent claims tighten the method context for needle-based auto-injectors:
Enforcement relevance
- If a commercial auto-injector has needle actuation plus a moving window indicator for “activated/delivered” confirmation, claims 15/16/19 become the most relevant dependent claim handles.
6. What are the practical infringement touchpoints for auto-injector makers?
A credible infringement theory under US 9,149,579 will typically map to:
- Same status window showing pre-activation status (e.g., visible medicament clarity, visible pre-actuation position of piston/elastomer/indicator).
- Moving indicator that changes position after activation and is viewable through the same window.
- Indicator movement tied to piston movement, not merely a separate cam or fixed visual flag.
- Use sequence aligning with the method:
- viewing before placing (or before actuation),
- actuating after contact with body or target surface,
- viewing post-actuation when indicator is in second position.
Highest-risk design features
- “Arming” confirmation (elastic/piston pre-position) and “delivered” confirmation (indicator second position) both visible through one window.
- Indicator that travels in a manner mechanically linked to piston displacement (claim 1) rather than solely linked to trigger movement.
7. What US patent landscape features typically surround this claim theme (window indicators, pistons, elastomer seals, gas actuation)?
US 9,149,579 fits within a dense auto-injector patent ecosystem where key competitive claims commonly cluster around:
- Visible window status indicators for user confirmation.
- Discoloration check of medicament through a window prior to use.
- Piston-to-elastomer movement designs that create predictable injection forces and sealing.
- Energy storage architectures (compressed gas, spring, mechanical drive).
- Needle deployment and safety sheath sequencing.
Because the patent number and its full bibliographic record are not provided here beyond the claim text, only claim-theme-level landscape can be asserted without risking an incorrect mapping to specific assignees, expiration dates, or citation sets.
8. How strong is the US patent estate based on claim construction signals (scope breadth vs. limiting features)?
Strength drivers
- Independent claim 1 contains multiple structural relationships that are common in commercial injectors but combined in a specific way: moving indicator with piston-linked motion + status window view logic pre- and post-activation.
- Dependent claims provide many fallback embodiments (colored indicator, obstructed-to-visible indicator transition, medicament discolored checks, compressed gas, contact-member stationary logic, needle/sheath behavior).
Scope pressure points
- Claims require a method that includes viewing and indicator viewability through the status window.
- Claims require indicator configured to move with the piston member.
- Claims require the elastomer member and its two positions.
Design-around pressure points
- Avoid coupling indicator motion to piston motion.
- Use a separate indicator location not viewable through the status window, or keep the post-activation status outside the window.
- Keep pre-activation confirmation from being viewable in the same window tied to claim-defined positions.
- Change elastomer-based two-position transition such that it does not map to “first position pre-activation” and “second position post-activation” in the claimed way (though equivalents may still be argued depending on claim construction).
9. What generic entry or biosimilar risk exists from this method patent?
This is a device/injector method patent, not a biologic/biosimilar formulation patent. The main risk to generics and biosimilars is indirect:
- If an entrant needs to use the same injector technology (status window with moving indicator configured to move with piston and provide in-window post-activation confirmation), licensing may be implicated for the device.
- If the entrant uses an alternative injector architecture that avoids the claim’s positional coupling and view logic, the method patent may not block the drug supply, but could still raise device licensing and labeling/IFU issues.
Without the Orange Book listing (if any) and without the issued patent’s title/assignee, no concrete exclusivity timeline can be asserted here.
10. Key takeaways
- US 9,149,579 claims a method that hinges on a status window delivering two-stage user confirmation: pre-activation first indication and post-activation second indication.
- The indicator’s piston-linked movement and in-window viewability at second indicator position are the central scope hooks.
- Dependent claims extend coverage to medicament auto-injectors, including discoloration checks, colored indicator portions, obstruction-to-visibility, compressed gas actuation, and needle deployment with safety sheath.
FAQs
- Can a non-gas injector still infringe US 9,149,579?
- Does the patent require the user to view the pre-activation status window before placing the injector?
- What happens if the post-activation indicator is visible only outside the status window?
- Is needle deployment and sheath coverage required for infringement of independent claim 1?
- How does “indicator configured to move with the piston member” narrow design options versus trigger-based indicators?
References (APA)
- United States Patent 9,149,579. (Patent claims provided in prompt).
More… ↓
⤷ Start Trial
|
